These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 31830637

  • 21. Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
    Yan J, Xu Y, Jin X, Zhang Q, Ouyang F, Han L, Zhan M, Li X, Liang B, Huang X.
    Eur J Med Chem; 2022 Jan 05; 227():113897. PubMed ID: 34649064
    [Abstract] [Full Text] [Related]

  • 22. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ, Ma CC, Zhang CM, Tang LQ, Liu ZP.
    Eur J Med Chem; 2020 Feb 01; 187():111968. PubMed ID: 31865012
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation.
    Aboomar NM, Essam O, Hassan A, Bassiouny AR, Arafa RK.
    Sci Rep; 2024 Apr 24; 14(1):9386. PubMed ID: 38653790
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pt(IV) complexes conjugating with chalcone analogue as inhibitors of microtubule polymerization exhibited selective inhibition in human cancer cells.
    Huang X, Huang R, Wang Z, Li L, Gou S, Liao Z, Wang H.
    Eur J Med Chem; 2018 Feb 25; 146():435-450. PubMed ID: 29407969
    [Abstract] [Full Text] [Related]

  • 27. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents.
    Zhang M, Liang YR, Li H, Liu MM, Wang Y.
    Bioorg Med Chem; 2017 Dec 15; 25(24):6623-6634. PubMed ID: 29126741
    [Abstract] [Full Text] [Related]

  • 28. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D, Qiu Z, Yao W, Liu Y, Huang H, Liao S, Luo Q, Xie L, Lin Z.
    Cancer Chemother Pharmacol; 2016 Jun 15; 77(6):1217-29. PubMed ID: 27107592
    [Abstract] [Full Text] [Related]

  • 29. 4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
    Yang L, Chen Y, He J, Njoya EM, Chen J, Liu S, Xie C, Huang W, Wang F, Wang Z, Li Y, Qian S.
    Bioorg Med Chem; 2019 Mar 15; 27(6):1087-1098. PubMed ID: 30773421
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and biological evaluation of arylcinnamide linked combretastatin-A4 hybrids as tubulin polymerization inhibitors and apoptosis inducing agents.
    Kamal A, Bajee S, Lakshma Nayak V, Venkata Subba Rao A, Nagaraju B, Ratna Reddy C, Jeevak Sopanrao K, Alarifi A.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2957-2964. PubMed ID: 27161282
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Synthesis of thiazole linked indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors.
    Guggilapu SD, Guntuku L, Reddy TS, Nagarsenkar A, Sigalapalli DK, Naidu VGM, Bhargava SK, Bathini NB.
    Eur J Med Chem; 2017 Sep 29; 138():83-95. PubMed ID: 28648953
    [Abstract] [Full Text] [Related]

  • 35. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
    Conesa-Milián L, Falomir E, Murga J, Carda M, Meyen E, Liekens S, Alberto Marco J.
    Eur J Med Chem; 2018 Mar 10; 147():183-193. PubMed ID: 29432949
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
    Mustafa M, Abdelhamid D, Abdelhafez EMN, Ibrahim MAA, Gamal-Eldeen AM, Aly OM.
    Eur J Med Chem; 2017 Dec 01; 141():293-305. PubMed ID: 29031074
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Insights into the mechanism of inhibition of tryptophan 2,3-dioxygenase by isatin derivatives.
    Pantouris G, Loudon-Griffiths J, Mowat CG.
    J Enzyme Inhib Med Chem; 2016 Dec 01; 31(sup1):70-78. PubMed ID: 27096472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.